MedTrace Logo

Antidepressant Therapy in Treating Bipolar Type II Major Depression

NCT00602537 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2017-04-25

Study results available
· View outcomes & findings →

Summary

This study will compare the safety and effectiveness of antidepressant therapy versus mood stabilizing therapy in treating people with bipolar type II major depression.

Conditions

Interventions

DRUG

Venlafaxine

75 to 375 mg

DRUG

Lithium Carbonate

300 to 2400 mg

Sponsors & Collaborators

Principal Investigators

  • Robert J. DeRubeis, PhD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00602537 on ClinicalTrials.gov